206
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Determination of isocyanate biomarkers in construction site workers

, , &
Pages 468-483 | Received 08 Sep 2006, Published online: 08 Oct 2008

References

  • Baur X. New aspects of isocyanate asthma. Lung 1990; 168: 606–613
  • Baur X, Marek W, Ammon J, Czuppon AB, Marczynski B, Raulf-Heimsoth M, Roemmelt H, Fruhmann G. Respiratory and other hazards of isocyanates. International Archives of Occupational and Environmental Health 1994; 66: 141–152
  • Beland FA, Kadlubar FF. Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. Chemical Carcinogenesis and Mutagenesis I, CS Cooper, PL Grover. Springer Verlag, Heidelberg 1990; 267–325
  • Bernstein JA. Overview of diisocyanate occupational asthma. Toxicology 1996; 111: 181–189
  • Bolognesi C, Baur X, Marczynski B, Norppa H, Sepai O, Sabbioni G. Carcinogenic risk of toluene diisocyanate and 4,4′-methylenediphenyl diisocyanate: epidemiological and experimental evidence. Critical Reviews in Toxicology 2001; 31: 737–772
  • Brochhagen, F. 1991. Isocyanates. In: Hutzinger, O. The Handbook of Environmental Chemistry, Vol. 3, Part G. Heidekberg: Springer Verlag p. 1–95.
  • Brown WE, Green AH, Cedel TE, Cairns J. Biochemistry of protein-isocyanate interactions: a comparison of the effects of aryl vs. alkyl isocyanates. Environmental Health Perspectives 1987; 72: 5–11
  • Brunmark P, Bruze M, Skerfving S, Skarping G. Biomonitoring of 4,4′-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans. International Archives of Occupational and Environmental Health 1995; 67: 95–100
  • Day BW, Jin R, Basalyga DM, Kramarik JA, Karol MH. Formation, solvolysis, and transcarbamoylation reactions of bis(S-glutathionyl) adducts of 2,4- and 2,6-diisocyanatotoluene. Chemical Research in Toxicology 1997; 10: 424–431
  • Day BW, Jin R, Karol MH. In vivo and in vitro reactions of toluene diisocyanate isomers with guinea pig hemoglobin. Chemical Research in Toxicology 1996; 9: 568–573
  • Delclos, KB, Kadlubar, FF. 1997. Carcinogenic aromatic amines and amides. In:. GT Bowden, Fischer, SMComprehensive Toxicology. Vol. 12. Chemical Carcinogens and Anticarcinogens. New York: Elsevier Science. p. 141–170.
  • Dewar M, Curry RW. Chronic obstructive pulmonary disease: diagnostic considerations. American Family Physician 2006; 73: 669–676
  • Deutsche Forschungsgemeinschaft (DFG). 2006. List of MAK and BAT Values 2005: Maximum Concentrations and Biological Tolerance Values at the Workplace. Report 41. WeilheimGermany: Wiley-VCH. p. 254.
  • EPA (US Environmental Protection Agency). 1998. Toxicological review of methylene diphenyl diisocyanate (MDI) (CAS No. 101-68-8 and 9016-87-9). In support of summary information on the Integrated Risk Information System (IRIS), Washington, DC: EPA.
  • European Commission. 2005. EUR 22104 EN European Union Risk Assessment Report: methylenediphenyl diisocyanate (MDI). Vol. 59. SJ Munn, Allanou, R, Aschberger, K, Cosgrove, O, Pakalin, S, Paya-Perez, A, Pellegrini, G, Schwarz-Schulz, B, Vegro, S. Luxembourg: Office for Official Publications of the European Communities. Environment and quality of life series. p. 221.
  • ERS (European Respiratory Society). 1993. Standardized lung function testing. Official statement of the European Respiratory Society. European Respiratory Journal 16(Suppl.):1–100.
  • Grunewalder E, Karol MH. Nitrocellulose-based RAST to detect IgE antibodies in workers hypersensitive to diphenylmethane-4,4′-diisocyanate. Allergy 1986; 41: 203–209
  • Hoymann, HG, Buschmann, J, Heinrich, U. 1995. Untersuchungen zur chronischen Toxizität/Kanzerogenität von 4,4′-Methylendiphenyl-Diisocyanat (MDI). Forschungsbericht 116 06 084. Hannover, Germany: Fraunhofer-Institut für Toxikologie und Aerosolforschung. p. 70.
  • IPCS-WHO (International Program on Chemical Safety World Health Organization). 2000. Concise International Chemical Assessment Document 27 Diphenylmethane diisocyanate (MDI). Stuttgart: IPCS.
  • Kadlubar, FF, Talaska, G, Lang, NP, Benson, RW, Roberts, DW. 1989. Assessment of exposure and susceptibility to aromatic amine carcinogens. In: H Bartsch, Hemminki, K, O'Neill, IKMethods for detecting DNA damaging agents in humans: applications in cancer epidemiology and prevention. IARC Scientific Publication 89. LyonFrance: International Agency for Research on Cancer. p. 166–180.
  • Karol MH. Respiratory effects of inhaled isocyanates. Critical Reviews in Toxicology 1986; 16: 349–379
  • Kazanis S, McClelland RA. Electrophilic intermediate in the reaction of glutathione and nitrosoarenes. Journal of the American Chemical Society 1992; 114: 3052–3059
  • Kennedy AL, Brown WE. Isocyanates and lung disease: experimental approaches to molecular mechanisms. Occupational Medicine 1992; 7: 301–329
  • Krone CA, Klingner TD. Isocyanates, polyurethane and childhood asthma. Pediatric Allergy and Immunology 2005; 16: 368–379
  • Lewalter J. Immunologische Aspekte bei der Verarbeitung isocyanathaltiger Produkte im Bereich Tiefbau. Prävention von arbeitsbedingten Gesundheitsgefahren und Erkrankungen, S Radandt, R Grieshaber, W Schneider. Schneider Monade Verlag und Agentur, Leipzig 1998; 184–200
  • Mapp CE, Saetta M, Maestrelli P, Di Stefano A, Chitano P, Boschetto P, Ciaccia A, Fabbri LM. Mechanisms and pathology of occupational asthma. The European Respiratory Journal 1994; 7: 554–544
  • Pearson PG, Slatter JG, Rashed MS, Han DH, Baillie TA. Carbamoylation of peptides and proteins in vitro by S-(N-methylcarbamoyl)glutathione and S-(N-methylcar-bamoyl) cysteine, two electrophilic S-linked conjugates of methyl isocyanate. Chemical Research in Toxicology 1991; 4: 436–444
  • Raulf-Heimsoth M, Baur X. Pathomechanisms and pathophysiology of isocyanate-induced diseases: summary of present knowledge. American Journal of Industrial Medicine 1998; 324: 137–143
  • Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and immunopathogenesis. International Immunopharmacology 2002; 2: 213–224
  • Ringe D, Turesky RJ, Skipper PL, Tannenbaum SR. Structure of the single stable hemoglobin adduct formed by 4-aminobiphenyl in vivo. Chemical Research in Toxicology 1988; 1: 22–24
  • Risch A, Smelt V, Lane D, Stanley L, van der Slot W, Ward A, Sim E. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients. Pharmacology and Toxicology 1996; 78: 235–240
  • Sabbioni G, Beyerbach A. Hemoglobin adducts of aromatic amines: diamines and polyaromatic amines. Journal of Chromatography B 2000; 744: 377–387
  • Sabbioni G, Hartley R, Henschler D, Hoellrigl-Rosta A, Koeber R, Schneider S. Isocyanate-specific hemoglobin adduct in rats exposed to 4,4′-methylenediphenyl diisocyanate. Chemical Research in Toxicology 2000; 13: 82–89
  • Sabbioni G, Hartley R, Schneider S. Synthesis of adducts with amino acids as potential dosimeters for the biomonitoring of humans exposed to toluenediisocyanate. Chemical Research in Toxicology 2001; 14: 1573–1583
  • Sabbioni G, Jones CR. Biomonitoring of arylamines and nitroarenes. Biomarkers 2002; 7: 347–421
  • Sabbioni G, Lamb JH, Farmer PB, Sepai O. Reactions of 4-methylphenyl isocyanate with amino acids. Biomarkers 1997; 2: 223–232
  • Sabbioni G, Schutze D. Hemoglobin binding of bicyclic aromatic amines. Chemical Research in Toxicology 1998; 11: 471–483
  • Sabbioni G, Sepai O. Comparison of hemoglobin binding, mutagenicity and carcinogenicity of arylamines and nitroarenes. Chimia 1995; 49: 374–380
  • Schutze D, Sepai O, Lewalter J, Miksche L, Henschler D, Sabbioni G. Biomonitoring of workers exposed to 4,4′-methylenedianiline or 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 1995; 16: 573–582
  • Schutze D, Sagelsdorff P, Sepai O, Sabbioni G. Synthesis and quantification of DNA adducts of 4,4′-methylenedianiline. Chemical Research in Toxicology 1996; 9: 1103–1112
  • Sennbro CJ, Lindh CH, Tinnerberg H, Gustavsson C, Littorin M, Welinder H, Jonsson BAG. Development, validation and characterization of an analytical method for quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4-and 2,6-toluene diisocyanate,1,5-naphthalene diisocyanate and 4,4′-methylenediphenyl diisocyanate. Biomarkers 2003; 8: 204–217
  • Sepai O, Henschler D, Sabbioni G. Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 1995a; 16: 2583–2587
  • Sepai O, Schütze D, Heinrich U, Hoymann HG, Henschler D, Sabbioni G. Hemoglobin adducts and urine metabolites of 4,4′-methylenedianiline after 4,4′-methylenediphenyl diisocyanate exposure to rats. Chemico-Biological Interactions 1995b; 97: 185–198
  • Skipper, PL, Tannenbaum, SR. 1994. Molecular dosimetry of aromatic amines in human populations. Environmental Health Perspectives, 102( Suppl.):17–21.
  • Slatter JG, Rashed MS, Pearson PG, Han DH, Baillie TA. Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities. Chemical Research in Toxicology 1991; 4: 157–161
  • van Welie RTH, van Dijck RGJM, Vermeulen NPE, van Sittert NJ. Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Critical Reviews in Toxicology 1992; 22: 271–306
  • Vock EH, Hoymann HG, Heinrich U, Lutz WK. 32P-postlabeling of a DNA adducts derived from 4,4′-methylenedianiline, in the olfactory epithelium of rats exposed by inhalation to 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 1996; 17: 1069–1073
  • Vock EH, Lutz WK. Distribution and DNA adduct formation of radiolabeled methylenediphenyl-4,4′-diisocyanate (MDI) in the rat after topical treatment. Toxicology Letters 1997; 92: 93–100
  • Wu J, Kreis IA, Griffiths D, Darling C. 1978 to 1990 workers: a lung function surveillance system from cross sectional study on lung function of coke oven. Occupational and Environmental Medicine 2002; 59: 816–823

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.